Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Mahendra Chemicals
WARNING LETTER
•Mahendra Chemicals•May 24, 2014

Mahendra Chemicals – FDA Warning Letter, May 24, 2014

Record Details

On July 13, 2015, the FDA issued a Warning Letter to Mahendra Chemicals following an inspection from May 19-24, 2014, which identified significant deviations from current Good Manufacturing Practice (CGMP) for Active Pharmaceutical Ingredients (APIs). These deviations render their APIs adulterated under Section 501(a)(2)(B) of the Federal Food, Drug, and Cosmetic Act.

Key violations include: 1. **Failure to record activities contemporaneously and destruction of original records:** Employees used "rough notes" for critical manufacturing data, then destroyed them after transcribing into batch records. Batch records were backdated, and lots were released before proper approvals, raising concerns about data integrity and reliability. 2. **Failure to prevent unauthorized data access/changes and ensure data completeness:** Laboratory systems lacked access controls, allowing deletion or alteration of raw data. There was no password functionality for GC, HPLC, or Karl Fischer Titrator instruments, and data acquisition software lacked active audit trails. 3. **Failure to train employees on operations and CGMP:** Multiple employees stated they hadn't received on-the-job training, and no training records were provided.

The FDA found the firm's June 16, 2014, response insufficient. The letter emphasizes that the quality system does not ensure data accuracy and integrity, and the quality unit lacks adequate authority. The FDA

Company
Mahendra Chemicals
Inspection date
May 24, 2014
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Thomas J. Cosgrove
View Company Profile

ID · 40e12d22-2d5a-45d6-8cc0-71f72455c788

Violation Codes3
21 U.S.C. 351(a)(2)(B)21 U.S.C. 381(a)(3)21 U.S.C. 356C(a)(1)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Mahendra Chemicals
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.